ELOXX PHARMACEUTICALS, INC. (ELOX) Total liabilities 2023–2025
ELOXX PHARMACEUTICALS, INC. (ELOX) total liabilities at each fiscal year-end, per SEC filings.
$17.2MFY2025 · since FY2023: $24.3M → $17.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $17.2M | -37.1% |
| FY2024 | $27.3M | +12.3% |
| FY2023 | $24.3M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More ELOX financial trends
ELOX RevenueELOX Net incomeELOX Net marginELOX Gross profitELOX Gross marginELOX Operating incomeELOX Operating marginELOX Operating cash flowELOX Free cash flowELOX Capital expendituresELOX Return on equityELOX Stock buybacksELOX Dividends paidELOX Total assetsELOX Shareholders’ equityELOX overview →